Nihon Kohden Corporation (NHNKY)
USD 14.63
(0.0%)
USD 14.63
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 23.44 Billion JPY | -5.89% |
| 2023 | 24.91 Billion JPY | -27.76% |
| 2022 | 34.48 Billion JPY | 8.99% |
| 2021 | 31.63 Billion JPY | 64.37% |
| 2020 | 19.24 Billion JPY | 2.73% |
| 2019 | 18.73 Billion JPY | 4.07% |
| 2018 | 18 Billion JPY | 4.99% |
| 2017 | 17.15 Billion JPY | -14.52% |
| 2016 | 20.06 Billion JPY | -4.11% |
| 2015 | 19.52 Billion JPY | -6.12% |
| 2014 | 20.78 Billion JPY | 26.71% |
| 2013 | 17.45 Billion JPY | 16.38% |
| 2012 | 15.1 Billion JPY | 13.39% |
| 2011 | 13.32 Billion JPY | 11.65% |
| 2010 | 11.93 Billion JPY | 14.6% |
| 2009 | 10.46 Billion JPY | -11.11% |
| 2008 | 11.81 Billion JPY | 12.88% |
| 2007 | 10.17 Billion JPY | 5.78% |
| 2006 | 9.92 Billion JPY | 7.42% |
| 2005 | 9.05 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 6.13 Billion JPY | 102.01% |
| 2024 Q3 | 3.99 Billion JPY | -34.98% |
| 2024 Q4 | 10.13 Billion JPY | 153.91% |
| 2024 FY | - JPY | -5.89% |
| 2024 Q1 | 3.03 Billion JPY | -71.76% |
| 2023 Q4 | 10.75 Billion JPY | 110.51% |
| 2023 Q3 | 5.11 Billion JPY | -18.71% |
| 2023 Q1 | 2.64 Billion JPY | -69.46% |
| 2023 Q2 | 6.28 Billion JPY | 137.84% |
| 2023 FY | - JPY | -27.76% |
| 2022 FY | - JPY | 8.99% |
| 2022 Q1 | 7.18 Billion JPY | -47.23% |
| 2022 Q2 | 11.79 Billion JPY | 64.25% |
| 2022 Q3 | 6.8 Billion JPY | -42.28% |
| 2022 Q4 | 8.65 Billion JPY | 27.1% |
| 2021 FY | - JPY | 64.37% |
| 2021 Q1 | 2.3 Billion JPY | -70.67% |
| 2021 Q2 | 7.41 Billion JPY | 221.78% |
| 2021 Q4 | 13.6 Billion JPY | 57.76% |
| 2021 Q3 | 8.62 Billion JPY | 16.3% |
| 2020 Q4 | 7.85 Billion JPY | 184.33% |
| 2020 Q1 | 764 Million JPY | -92.28% |
| 2020 Q2 | 7.27 Billion JPY | 852.49% |
| 2020 Q3 | 2.76 Billion JPY | -62.02% |
| 2020 FY | - JPY | 2.73% |
| 2019 Q3 | 2.7 Billion JPY | -51.18% |
| 2019 FY | - JPY | 4.07% |
| 2019 Q1 | 1.36 Billion JPY | -83.75% |
| 2019 Q2 | 5.54 Billion JPY | 305.93% |
| 2019 Q4 | 9.89 Billion JPY | 265.84% |
| 2018 Q1 | 895 Million JPY | -90.25% |
| 2018 Q4 | 8.4 Billion JPY | 106.39% |
| 2018 FY | - JPY | 4.99% |
| 2018 Q3 | 4.07 Billion JPY | -7.05% |
| 2018 Q2 | 4.38 Billion JPY | 389.39% |
| 2017 Q3 | 4.22 Billion JPY | -15.48% |
| 2017 Q2 | 5 Billion JPY | 729.72% |
| 2017 Q1 | -794 Million JPY | -108.17% |
| 2017 FY | - JPY | -14.52% |
| 2017 Q4 | 9.18 Billion JPY | 117.3% |
| 2016 Q1 | 1.37 Billion JPY | -83.72% |
| 2016 Q3 | 4.09 Billion JPY | -11.75% |
| 2016 Q4 | 9.72 Billion JPY | 137.55% |
| 2016 FY | - JPY | -4.11% |
| 2016 Q2 | 4.63 Billion JPY | 238.05% |
| 2015 Q1 | 1.71 Billion JPY | -83.32% |
| 2015 FY | - JPY | -6.12% |
| 2015 Q4 | 8.43 Billion JPY | 74.64% |
| 2015 Q3 | 4.82 Billion JPY | -18.82% |
| 2015 Q2 | 5.94 Billion JPY | 246.1% |
| 2014 Q4 | 10.3 Billion JPY | 113.78% |
| 2014 FY | - JPY | 26.71% |
| 2014 Q1 | 2.64 Billion JPY | -62.63% |
| 2014 Q2 | 4.51 Billion JPY | 70.55% |
| 2014 Q3 | 4.81 Billion JPY | 6.64% |
| 2013 Q4 | 7.08 Billion JPY | 76.8% |
| 2013 FY | - JPY | 16.38% |
| 2013 Q1 | 2.41 Billion JPY | -64.05% |
| 2013 Q2 | 4 Billion JPY | 65.69% |
| 2013 Q3 | 4 Billion JPY | 0.02% |
| 2012 Q3 | 3.24 Billion JPY | -7.08% |
| 2012 Q4 | 6.72 Billion JPY | 107.62% |
| 2012 Q2 | 3.48 Billion JPY | 110.88% |
| 2012 Q1 | 1.65 Billion JPY | -70.89% |
| 2012 FY | - JPY | 13.39% |
| 2011 FY | - JPY | 11.65% |
| 2011 Q1 | 1.45 Billion JPY | -65.1% |
| 2011 Q2 | 3.56 Billion JPY | 145.12% |
| 2011 Q3 | 2.49 Billion JPY | -30.15% |
| 2011 Q4 | 5.68 Billion JPY | 127.92% |
| 2010 Q2 | 3.52 Billion JPY | 136.83% |
| 2010 Q1 | 1.48 Billion JPY | -61.94% |
| 2010 FY | - JPY | 14.6% |
| 2010 Q4 | 4.17 Billion JPY | 51.54% |
| 2010 Q3 | 2.75 Billion JPY | -21.88% |
| 2009 FY | - JPY | -11.11% |
| 2009 Q3 | 1.41 Billion JPY | -13.11% |
| 2009 Q4 | 3.91 Billion JPY | 176.91% |
| 2009 Q2 | 1.62 Billion JPY | 0.0% |
| 2008 FY | - JPY | 12.88% |
| 2007 FY | - JPY | 5.78% |
| 2006 FY | - JPY | 7.42% |
| 2005 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AVITA Medical, Inc. | -39.56 Million USD | 59352.787% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 2014275.258% |
| Össur hf. | 137.38 Million USD | -16965.679% |
| QHSLab, Inc. | -91.29 Thousand USD | 25681148.93% |
| Wellstar International, Inc. | -1.35 Million USD | 1728422.072% |
| Össur hf. | 137.38 Million USD | -16965.679% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | -58.46 Thousand USD | 40103758.849% |
| Aurora Spine Corporation | -454.37 Thousand USD | 5159900.871% |
| BrainsWay Ltd. | -2.31 Million USD | 1014595.889% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 8547622.695% |
| Hamilton Thorne Ltd. | 5.52 Million USD | -424503.264% |
| Vivos Inc. | -2.79 Million USD | 839476.101% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 11859516.969% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 1405208.855% |
| Zecotek Photonics Inc. | -3.44 Million USD | 681201.348% |
| Avitar, Inc. | -1.66 Million USD | 1405841.565% |
| Nanomix Corporation | -8.13 Million USD | 288130.358% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | -239768.804% |
| Theraclion SA | -2.05 Million USD | 1143320.209% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | -1.45 Million USD | 1614601.522% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 1361689.189% |
| Lombard Medical, Inc. | -28.06 Million USD | 83629.286% |
| ALR Technologies Inc. | -6.4 Million USD | 366410.096% |
| Stratec SE | 39.91 Million USD | -58638.788% |
| Vycor Medical, Inc. | 100.94 Thousand USD | -23225879.018% |
| Heart Tronics, Inc. | -14.85 Million USD | 157905.708% |
| MicroPort Scientific Corporation | -347.57 Million USD | 6845.244% |
| VMS Rehab Systems, Inc. | -68.55 USD | 34201313010.284% |
| NewCardio, Inc. | -9.37 Million USD | 250064.63% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 750100.0% |
| Ingen Technologies, Inc. | -8639.00 USD | 271385677.034% |
| Odyssey Group International, Inc. | -2.13 Million USD | 1096647.641% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 6187650.474% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 3316083.763% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 256273.542% |
| IR-Med Inc. | -4.89 Million USD | 479351.84% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 176685.6% |
| Polarean Imaging plc | -11.19 Million USD | 209524.018% |
| United American Healthcare Corporation | -59 Thousand USD | 39737388.136% |
| ECGI Holdings, Inc. | -2.99 Million USD | 784100.439% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | 19825229.588% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 3726360.881% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 4561162.205% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | -5140670.951% |
| Urologix, Inc. | -6.34 Million USD | 369661.791% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 1891800.643% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 3060936.825% |
| SS Innovations International, Inc. | -20.37 Million USD | 115161.894% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 10522140.41% |
| Smith & Nephew plc | 1 Billion USD | -2238.452% |
| NIOX Group Plc | 11.07 Million USD | -211591.091% |
| Fuse Medical, Inc. | 1.83 Million USD | -1277336.692% |
| Broncus Holding Corporation | -25.19 Million USD | 93140.093% |
| Brain Scientific Inc. | -7.93 Million USD | 295610.584% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 249756.476% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | 127418578.261% |